Neratinib And Tepotinib Combination In Advanced Breast Cancer And Inflammatory Breast Cancer Patients With Abnormal Her2 And C-Met Pathway Activity As Measured By The Celsignia Signaling Pathway Activity Test
CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要